ORPHA:157973
Congenital muscular dystrophy due to LMNA mutation
Also known as: L-CMD · LMNA-related congenital muscular dystrophy
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
3,051
Trials
1
Interventional, condition-specific
Researchers
1,371
Distinct authors in sample
Gene link
—
Readiness
4/6
Stages with a signal
Clinical definition (Orphanet)
A rare muscular characterized by prominent axial , predominantly proximal muscle weakness in upper limbs and distal in lower limbs, joint contractures (initially distal, later proximal), spinal rigidity, and respiratory insufficiency, in the presence of moderately elevated serum creatine kinase. Cardiac arrhythmias and sudden death have also been reported.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0013178
- MeSH:C567708
- OMIM:613205
- UMLS:C2750785
- NCIT:C148369
Additional Mondo synonyms (4)
LMNA congenital muscular dystrophy · congenital muscular dystrophy caused by mutation in LMNA · muscular dystrophy Congenital, LMNA-related · muscular dystrophy, congenital
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
4/6 stages with a signal
An interventional trial matched this condition name on ClinicalTrials.gov — see trials below.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
3,051 matched papers (1,409 in last 10 years) Source
- Phenotype characterisedPresent
52 HPO annotations (e.g. Hypotonia; Gait disturbance; Flexion contracture) Source
- Animal modelPresent
1 genotype model (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPresent
1 matched on ClinicalTrials.gov (1 recruiting in sample)
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
52
Associated phenotypes · MONDO:0013178
- Hypotonia
- Gait disturbance
- Flexion contracture
- Congestive heart failure
- Talipes
Showing 5 of 52 — open Monarch for the full list.
Animal models (Monarch / Alliance)
1
Model associations linked to this Mondo ID
- Lmnatm2.1Gbon/Lmnatm2.1Gbon [background:] involves: 129 * C57BL/6·MGI:5306920·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
3,051
3,051 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
3,051 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
1,409 in the last 10 years · low confidence
Phrase hits: 3,051 · MeSH hits: 0
Who's working on it?
1,371
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
People publishing on this condition (sampled Europe PMC records). Affiliation is the most recent found in that sample.
- 01Bonne G11 papers · 2025
Sorbonne Université, INSERM UMRS_974, Center of Research in Myology, 75013, Paris, France.
Papers in Europe PMC - 02Sarquella-Brugada G6 papers · 2026
Medical Science Department, School of Medicine, University of Girona, Girona, Spain.
Papers in Europe PMC - 03Bönnemann CG5 papers · 2024
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: carsten.bonnemann@nih.gov.
Papers in Europe PMC - 04Cesar S5 papers · 2026
Pediatric Arrhythmias, Inherited Cardiac Diseases and Sudden Death Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
Papers in Europe PMC - 05Komaki H5 papers · 2026
1Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.
Papers in Europe PMC - 06Muntoni F5 papers · 2026
The Dubowitz Neuromuscular Centre, University College London, and MRC Centre for Neuromuscular Diseases, Neurosciences Unit, Great Ormond Street Hospital, United Kingdom.
Papers in Europe PMC - 07Nascimento A5 papers · 2024
Department of Pediatrics, Peking University First Hospital, Beijing, China.
Papers in Europe PMC - 08
- 09Ben Yaou R4 papers · 2021
Sorbonne Université, Inserm, Center of Research in Myology, G.H. Pitié-Salpêtrière, Paris, France.
Papers in Europe PMC - 10Bertrand AT4 papers · 2020
Sorbonne Université, Inserm, Center of Research in Myology, Institute of Myology, F-75013 Paris, France.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
1
interventional trials for this specific condition
1 interventional trial matched this specific condition name; 1 currently recruiting in our sample. 6 trials are registered for congenital muscular dystrophy, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026
1 interventional trial — more than 77.2% of diseases in the trials denominator have none at all (5501 of 7126; this disease is at the 80.1th percentile).
low confidence · 80.1th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
1 interventional trials matched after quoted-phrase search and title/condition post-filter.
- NCT05394506·RECRUITING·Modifying Factors in Striated Muscle Laminopathies
Not reviewed·Conditions: Laminopathies · Emery Dreifuss Muscular Dystrophy 2 · LMNA-Related Congenital Muscular Dystrophy · Dilated Cardiomyopathy-1A·Matched via name phrase
Broader category: congenital muscular dystrophy
6
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT05982119·RECRUITING·Assessments in Patients With Muscular Pathology and in Control Subjects : The ActiLiège Next Study
Not reviewed·Conditions: Duchenne Muscular Dystrophy · Fascioscapulohumeral Muscular Dystrophy · Myotonic Dystrophy 1 · Charcot-Marie-Tooth·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 1 · after dedupe 1 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 1 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (1)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Congenital muscular dystrophy due to LMNA mutation — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Congenital muscular dystrophy due to LMNA mutation" OR "L-CMD" OR "LMNA-related congenital muscular dystrophy" OR "LMNA congenital muscular dystrophy" OR "congenital muscular dystrophy caused by mutation in LMNA" OR "muscular dystrophy Congenital, LMNA-related" OR "muscular dystrophy, congenital"
MeSH descriptor terms unioned into the query: Muscular Dystrophy, Congenital, Lmna-Related
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Congenital muscular dystrophy due to LMNA mutation" OR "L-CMD" OR "LMNA-related congenital muscular dystrophy" OR "LMNA congenital muscular dystrophy" OR "congenital muscular dystrophy caused by mutation in LMNA" OR "muscular dystrophy Congenital, LMNA-related" OR "muscular dystrophy, congenital" OR "Muscular Dystrophy, Congenital, Lmna-Related"
Interventional trials matched via: phrase (mesh = registered under a MeSH descriptor no name phrase would catch; recall-expansion = gene / selected parent terms used only for trials).
Study-type breakdown: 1 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"congenital muscular dystrophy"
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (3051) is implausibly high for prevalence class "<1 / 1 000 000" — treat as possible over-matching, not a measure of research intensity
Ingested 2026-07-27T08:03:42.792Z
